Stockreport

Travere gains on full FDA approval for kidney drug Filspari [Seeking Alpha]

Ligand Pharmaceuticals Incorporated  (LGND) 
Last ligand pharmaceuticals incorporated earnings: 2/6 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investor.ligand.com
PDF The once-daily oral medication developed by Travere ( TVTX ) in partnership with Ligand Pharmaceuticals ( NASDAQ: LGND ) was granted the FDA's accelerated approval [Read more]